Trials / Completed
CompletedNCT00757679
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran. An Exploratory Placebo-controlled Clinical Trial in Fibromyalgia Out-patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the antinociceptive effect of 7 weeks of treatment with milnacipran, compared to placebo, in fibromyalgia out-patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Milnacipran | capsules |
| DRUG | Placebo | capsules |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-09-23
- Last updated
- 2013-07-11
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00757679. Inclusion in this directory is not an endorsement.